cemiplimab plus fianlimab: Clinical Trials

1 trial of cemiplimab plus fianlimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow cemiplimab plus fianlimab: new trials by email Literature Review of cemiplimab plus fianlimab trials Research Report on cemiplimab plus fianlimab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Cemiplimab, cemiplimab plus fianlimab, cemiplimab + REGN7075 - Colo-rectal Cancer
Phase 2RecruitingNSABP Foundation Inc792026-04-172026-09-03

Conditions studied

Colonic Neoplasms (1)

Sponsors

NSABP Foundation Inc (1)

Countries

United States (1)

Results publications

PMID 42345857